The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
11 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,122,150 in first-year total cost, median $276,286.
Most frequent study sections
- Special Emphasis Panel[ZRG1 SBIB-A (56)]5
- Special Emphasis Panel[ZRG1 SBIB-C (56)]4
- Special Emphasis Panel[ZRG1 SBIB-L (56)]2
Most frequent institutions
- STANFORD UNIVERSITY2
- UNIVERSITY OF CALIFORNIA, SAN DIEGO2
- UNIVERSITY OF TX MD ANDERSON CAN CTR2
- CHILDREN'S RESEARCH INSTITUTE1
- SLOAN-KETTERING INST CAN RESEARCH1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2021 | Multi-atlas and whole body radiomics approaches for image-guided treatment of gynecologic cancers1R01CA255780-01 | MELL, LOREN K. | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $276,286 | ZRG1 |
| 2021 | A novel PARP inhibitor PET tracer for breast cancer1R01CA249329-01A1 | LIN, LILIE LEMINGPIWNICA-WORMS, DAVID | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $265,073 | ZRG1 |
| 2020 | Next Generation Sentinel Node Mapping1R01CA238686-01A1 | CHIN, FREDERICK TROSENTHAL, EBEN L. | STANFORD UNIVERSITY, CA | $326,765 | ZRG1 |
| 2020 | PSMA/MR-guided Stereotactic Body Radiotherapy for High Risk Prostate Cancer1R01CA249615-01 | KANG, JOSEPHINE M | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $310,185 | ZRG1 |
| 2020 | Imaging Biomarkers for Glioma Treatment Response1R01CA245097-01A1 | RECHT, LAWRENCE DSPIELMAN, DANIEL M | STANFORD UNIVERSITY, CA | $275,857 | ZRG1 |
| 2019 | Immunogenic Priming with Lu-PSMA Targeted Therapy in Advanced Prostate Cancer1R01CA229354-01A1 | AGGARWAL, RAHULHOPE, THOMAS | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $366,367 | ZRG1 |
| 2019 | [18F]FAZA PET/CT for Monitoring Target Engagement of a Novel Complex I Inhibitor1R01CA231506-01A1 | PIWNICA-WORMS, DAVID | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $305,069 | ZRG1 |
| 2019 | Optimizing Thermal Ablation for Colon Cancer Liver Metastases: Rapid Tissue Analysis Allowing for Immediate Retreatment; Metabolic Imaging Biomarker Validation; and Predictive Genetic Signatures1R01CA240569-01 | SOFOCLEOUS, CONSTANTINOS THASOS | SLOAN-KETTERING INST CAN RESEARCH, NY | $293,870 | ZRG1 |
| 2019 | Image-Guided Cognitive-Sparing Radiosurgery for Brain Metastases: Avoidance of Eloquent White Matter and Hippocampal Regions1R01CA238783-01 | HATTANGADI-GLUTH, JONA A | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $257,573 | ZRG1 |
| 2019 | Clinical Efficacy of Focused Ultrasound (MR-HIFU) Treatment of Symptomatic Osteoid Osteoma in Pediatrics1R01CA227454-01A1 | SHARMA, KARUN V | CHILDREN'S RESEARCH INSTITUTE, DC | $240,743 | ZRG1 |
| 2019 | Ameliorating lymphocyte depletion and functional impairment following lung SBRT1R01CA234281-01A1 | WIJESOORIYA, KRISHNI | UNIVERSITY OF VIRGINIA, VA | $204,362 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.